© 1993 by Oxford University Press
Elevated Levels of the Angiogenic Peptide Basic Fibroblast Growth Factor in Urine of Bladder Cancer Patients
Mai Nguyen, Hiroyuki Watanabe, Andrew E. Budson, Jerome P. Richie, and Judah Folkman
| You have reached the most complete version of this article accessible without further authentication.
More complete versions are available. Link to article |
Article topics:
- Developmental Biology..bFGF
- Oncology..Bladder Cancer
- Oncology..Detection/Screening and Prognosis of Bladder Cancer
- Oncology..Treatment Options for Bladder Cancer
- Physiology..Platelet-Derived Growth Factor
- Cell Biology..Fibroblast Growth Factor
- Oncology..Surgery
- Oncology..Diagnosis
- Developmental Biology..Angiogenesis
- Oncology..Early Detection/Screening
- Pharmacology..Growth Substances
- Oncology..Growth Factors
This article has been cited by other articles:
![]() |
G. Sonpavde, A. A. Elfiky, and J. E. Rosenberg Review: Novel agents for advanced bladder cancer Therapeutic Advances in Medical Oncology, July 1, 2009; 1(1): 37 - 50. [Abstract] [PDF] |
||||
![]() |
S. E. Pories, D. Zurakowski, R. Roy, C. C. Lamb, S. Raza, A. Exarhopoulos, R. G. Scheib, S. Schumer, C. Lenahan, V. Borges, et al. Urinary Metalloproteinases: Noninvasive Biomarkers for Breast Cancer Risk Assessment Cancer Epidemiol. Biomarkers Prev., May 1, 2008; 17(5): 1034 - 1042. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Marler, S. J. Fishman, S. M. Kilroy, J. Fang, J. Upton, J. B. Mulliken, P. E. Burrows, D. Zurakowski, J. Folkman, and M. A. Moses Increased Expression of Urinary Matrix Metalloproteinases Parallels the Extent and Activity of Vascular Anomalies Pediatrics, July 1, 2005; 116(1): 38 - 45. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Rousseau, F. Larrieu-Lahargue, S. Javerzat, F. Guilhem-Ducleon, F. Beermann, and A. Bikfalvi The tyrp1-Tag/tyrp1-FGFR1-DN Bigenic Mouse: A Model for Selective Inhibition of Tumor Development, Angiogenesis, and Invasion into the Neural Tissue by Blockade of Fibroblast Growth Factor Receptor Activity Cancer Res., April 1, 2004; 64(7): 2490 - 2495. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. M. Mian, C. P. N. Dinney, C. E. Bermejo, P. Sweeney, C. Tellez, X. D. Yang, J. M. Gudas, D. J. McConkey, and M. Bar-Eli Fully Human Anti-Interleukin 8 Antibody Inhibits Tumor Growth in Orthotopic Bladder Cancer Xenografts via Down-Regulation of Matrix Metalloproteases and Nuclear Factor-{kappa}B Clin. Cancer Res., August 1, 2003; 9(8): 3167 - 3175. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. I. Izawa and C. P.N. Dinney The role of angiogenesis in prostate and other urologic cancers: a review Can. Med. Assoc. J., March 1, 2001; 164(5): 662 - 670. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Bok, S. Halabi, D. T. Fei, C. R. Rodriquez, D. F. Hayes, N. J. Vogelzang, P. Kantoff, M. A. Shuman, and E. J. Small Vascular Endothelial Growth Factor and Basic Fibroblast Growth Factor Urine Levels as Predictors of Outcome in Hormone-refractory Prostate Cancer Patients: A Cancer and Leukemia Group B Study Cancer Res., March 1, 2001; 61(6): 2533 - 2536. [Abstract] [Full Text] |
||||
![]() |
K. Inoue, J. W. Slaton, S. J. Kim, P. Perrotte, B. Y. Eve, M. Bar-Eli, R. Radinsky, and C. P. N. Dinney Interleukin 8 Expression Regulates Tumorigenicity and Metastasis in Human Bladder Cancer Cancer Res., April 1, 2000; 60(8): 2290 - 2299. [Abstract] [Full Text] |
||||
![]() |
R. Z. Florkiewicz, J. Anchin, and A. Baird The Inhibition of Fibroblast Growth Factor-2 Export by Cardenolides Implies a Novel Function for the Catalytic Subunit of Na+,K+-ATPase J. Biol. Chem., January 2, 1998; 273(1): 544 - 551. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Pepper Manipulating Angiogenesis: From Basic Science to the Bedside Arterioscler Thromb Vasc Biol, April 1, 1997; 17(4): 605 - 619. [Abstract] [Full Text] |
||||
![]() |
W. W. Li, V. W. Li, D. Tsakayannis, X. Xing, L. L. Wood, R. J. Cote, D. G. Skinner, and P. A. Jones p53 and Bladder Cancer N. Engl. J. Med., April 6, 1995; 332(14): 957 - 958. [Full Text] |
||||
![]() |
W. H. Hendren Pediatric Surgery: Then and Now Arch Surg, April 1, 1994; 129(4): 345 - 352. [Abstract] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||









